Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings: Dec. 19, 2013

Aethersys, Daiichi Sankyo, Galectin Therapeutics, Genzyme, GSK, NewLink Genetics, Pfizer, Sandoz, Sanofi, Theravance, Vertex

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical Galectin publishes preclnical NASH data . . . read more Phase I NewLink launches F-I-H trial of renal immunotherapy . . . read more Phase II Pfizer completes enrollment in UC trial . . . read more Phase III Sandoz begins Humira biosimilar trial . . . read more Vertex CF trial misses primary endpoint . . . read more Filings Daiichi Sankyo submits Lixiana sNDA in Japan . . . read more Approvals GSK, Theravance COPD treatment approved . . . read more Lemtrada approved in Australi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters